Found 0 matching trials
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
PHASE1The purpose of this study is to compare the relative bioavailability of 3 m...
Location
PRACS Institute, Ltd.
A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder
PHASE4The purpose of this study is to evaluate the long-term (6-month) efficacy, ...
Location
Pfizer Investigational Site
Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions
PHASE1This study will compare the relative bioavailability (rate and extent of ab...
Location
PRACS Institute, Ltd.
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
PHASE1The purpose of this study is to compare the relative bioavailability of 3 m...
Location
PRACS Institute, Ltd.
An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites
PHASE1Study to evaluate if Xanax sustained release tablets manufactured at two di...
Location
Pfizer Investigational Site
A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks
PHASE4The purpose of this study is to assess the long-term safety and tolerabilit...
Location
Pfizer Investigational Site